SALT LAKE CITY, Nov. 3, 2011 (GLOBE NEWSWIRE) -- Myrexis, Inc. (Nasdaq:MYRX), a biotechnology company focused on the development of small molecule therapeutics with novel chemical structures and distinct mechanisms of action, today announced it will hold a conference call on Thursday, November 9, 2011 at 4:30 p.m. ET (1:30 p.m. PT) to discuss financial results for its fiscal first quarter 2012 ended September 30, 2011.
